Penumbra (PEN) Down 8% Since Last Earnings Report: Can It Rebound?
Werte in diesem Artikel
It has been about a month since the last earnings report for Penumbra (PEN). Shares have lost about 8% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Penumbra due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.How Have Estimates Been Moving Since Then?It turns out, estimates revision have trended downward during the past month.The consensus estimate has shifted -18.09% due to these changes.VGM ScoresAt this time, Penumbra has a great Growth Score of A, though it is lagging a lot on the Momentum Score front with a D. Following the exact same course, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Penumbra has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.Performance of an Industry PlayerPenumbra is part of the Zacks Medical - Instruments industry. Over the past month, Steris (STE), a stock from the same industry, has gained 1.8%. The company reported its results for the quarter ended December 2024 more than a month ago.Steris reported revenues of $1.37 billion in the last reported quarter, representing a year-over-year change of -1.8%. EPS of $2.32 for the same period compares with $2.22 a year ago.Steris is expected to post earnings of $2.58 per share for the current quarter, representing a year-over-year change of +7.1%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.1%.Steris has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of B.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Penumbra, Inc. (PEN): Free Stock Analysis Report STERIS plc (STE): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Penumbra und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Penumbra
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Penumbra
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Penumbra Inc
Analysen zu Penumbra Inc
Datum | Rating | Analyst | |
---|---|---|---|
15.12.2017 | Penumbra Market Perform | BMO Capital Markets | |
24.10.2016 | Penumbra Outperform | BMO Capital Markets | |
30.11.2015 | Penumbra Buy | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
15.12.2017 | Penumbra Market Perform | BMO Capital Markets | |
24.10.2016 | Penumbra Outperform | BMO Capital Markets | |
30.11.2015 | Penumbra Buy | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Penumbra Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen